TL;DR
Get everyday helpers delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
MedPage Today’s Oct. 11, 2026, “What We Heard This Week” roundup presents eight health-related quotations from clinicians and health leaders. The comments address unapproved herpes treatments sold on Amazon, the federal response to measles, infection prevention and research findings; the roundup is not itself a report of new study results or policy changes.
MedPage Today published a weekly roundup of eight health-related quotations on Oct. 11, 2026, including a physician’s criticism of unapproved herpes treatments being sold on Amazon and a former federal infectious-disease director’s assessment of the government’s response to a U.S. measles outbreak. The collection captures reactions to several health developments, but it does not provide a new, independently detailed account of the underlying events.
Jeffrey Klausner, MD, MPH, of Herpes Cure Advocacy, was quoted responding to news that the Food and Drug Administration had warned Amazon over the sale of unapproved herpes treatments. “The public should not be subject to these quack medicines,” he said. The roundup does not reproduce the FDA warning or identify the products, so the details of the agency’s action and the items at issue are not specified in this source.
Jeanne Marrazzo, MD, MPH, former director of the National Institute of Allergy and Infectious Diseases, criticized the federal government’s response to a U.S. measles outbreak, calling it “extremely underwhelming and frankly shameful.” The excerpt offers no further account of the outbreak or the federal response. Other comments covered 18 nurses running for Congress, hospital efforts to prevent catheter-associated urinary tract infections, and a study of children exposed to vaping and combustible tobacco.
The roundup also included remarks about a spike in a rare fungal infection, a small study of radiosurgical capsulotomy for treatment-resistant depression and suicidal ideation, and research into optogenetic therapy for advanced retinitis pigmentosa. Those comments describe the speakers’ views of the findings; they do not establish the therapies’ effectiveness or provide enough study detail to assess the evidence.
What the Eight Quotes Highlight
The roundup brings together concerns about consumer protection, infectious disease and patient safety, alongside early-stage or developing research. Its comments may help readers identify issues being discussed by clinicians and health leaders, but the format is selective: a quotation is not a substitute for the evidence, agency documents or full reporting behind the topic.
That distinction matters especially for treatment claims. Klausner’s objection refers to products described as unapproved, while Khattab’s cautious “potentially” was attached to a small study of a brain procedure. Neither quote by itself establishes the risks, benefits or regulatory status of a treatment. Readers seeking decisions about care would need reliable clinical information and advice from a qualified professional.
As an affiliate, we earn on qualifying purchases.
Eight Comments, Several Health Topics
MedPage Today describes the item as a collection of quotations heard by its reporters during the week. It was published on October 11, 2026, and lists eight speakers with their professional affiliations and the subjects they were discussing. The collection ranges from public-health policy to clinical research rather than following one event in depth.
Beyond Klausner and Marrazzo, the speakers included Jennifer Mensik Kennedy, president of the American Nurses Association, who commented on nurses seeking congressional office; Sanjay Saint of Northwell Health, on hospital efforts to reduce catheter use and duration; and Brian Jenssen of Children’s Hospital of Philadelphia, on asking about vaping as well as smoking in homes where children have asthma. The remaining comments addressed a fungal infection, depression treatment research and optogenetic therapy for vision loss.
““The public should not be subject to these quack medicines.””
— Jeffrey Klausner, MD, MPH, of Herpes Cure Advocacy
Details Behind the Comments
The source is a short quotation roundup, not a full account of the events and studies it mentions. It does not provide the FDA warning, product names, agency response, measles case figures or outbreak timeline. It also does not identify the particular fungal infection or explain the reported spike, including its scale, location or period.
For the research comments, the roundup gives no methods, participant numbers beyond describing one study as small, comparison groups, follow-up periods or complete results. It is not clear from this material whether the studies have been peer-reviewed or whether the interventions are available beyond research settings. The comments should be read as attributed reactions, not as proof of clinical benefit or risk.
Follow the Underlying Evidence
The roundup itself announces no scheduled follow-up, new policy or next research milestone. To clarify the claims, readers would need the FDA’s underlying notice and any response from Amazon, as well as official updates on the measles outbreak and federal actions. The full research papers or presentations would be needed to evaluate the studies mentioned.
Until those materials are reviewed, the confirmed development here is the publication of MedPage Today’s weekly collection and the fact that the named speakers made these comments. The scope and implications of the underlying developments remain only partly described in the excerpt.
Key Questions
What did MedPage Today publish?
It published an Oct. 11, 2026, roundup of eight health-related quotations from clinicians and health leaders on topics including unapproved herpes treatments, measles, infection prevention and medical research.
What did Jeffrey Klausner say about herpes treatments?
Klausner said, “The public should not be subject to these quack medicines,” in response to news that the FDA had warned Amazon about selling unapproved herpes treatments. The supplied roundup does not identify the products or reproduce the warning.
Did the roundup report new measles figures?
No. It quotes former NIAID director Jeanne Marrazzo criticizing the federal response to a U.S. measles outbreak, but gives no case counts, locations or timeline.
Do the quoted research comments prove that the treatments work?
No. The roundup summarizes reactions to studies, including a small study of radiosurgical capsulotomy and research into optogenetic therapy. It does not provide enough methods or results to assess effectiveness, safety or clinical availability.
Source: rss
Columbus Day / Indigenous Peoples' Day Picks
long weekend sales
As an affiliate, we earn on qualifying purchases.
